Adult Flu Vaccines — Drugs and Biologicals

HEALTH AND HUMAN SERVICES, DEPARTMENT OF · CENTERS FOR DISEASE CONTROL AND PREVENTION · CDC OFFICE OF ACQUISITION SERVICES is soliciting FY27-28 Adult Flu Vaccines — Drugs and Biologicals. Solicitation number 75D30126R73517. Classified under NAICS 325412 — Pharmaceutical Preparation Manufacturing. Product/service code 6505 — DRUGS AND BIOLOGICALS. Place of performance: GA, USA. Responses are due by 16 September 2026 17:00 UTC. Posted on SAM.gov, the US federal contract opportunities system; registration is required to bid.

The Centers for Disease Control and Prevention (CDC) awards one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the purchase of standard commercial adult vaccines.  The establishment of these contracts provides opportunity to utilize Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. These funds provide vaccines for state and local health departments to use in populations at greatest risk for under vaccination and disease.  The 317 program as established under Section 317(j) of the Public Health Service Act, works to ensure that adults receive appropriate immunization by partnering with healthcare providers in the public and private sectors.  The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage.  The vaccines awarded under these contracts will be purchased for the National Center for Immunization and Respiratory Disease’s (NCIRD’s) immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act.  In addition, awardees may opt to purchase additional quantities of vaccine for adults under any resulting contract using state and local funds.